High Absorption Liposomal Griffonia Seed Extract Powder 5-HTP 5-Hydroxytryptophan CAS 56-69-9 Bulk Supply
Nutritional Profile: Griffonia Seed Extract
Griffonia Seed Extract is the most significant natural source of 5-HTP (5-Hydroxytryptophan), a direct amino acid precursor to the neurotransmitter Serotonin. It plays a critical role in regulating mood, sleep cycles, and appetite, making it a cornerstone of mental wellness supplementation.
The primary challenge with standard 5-HTP is its rapid peripheral conversion. If 5-HTP converts to Serotonin in the gut or bloodstream before reaching the brain, it can cause gastrointestinal discomfort and reduced neurological efficacy. High-efficiency delivery is essential to ensure the compound reaches its target across the blood-brain barrier.
In the functional ingredients market, "liposome" has become synonymous with premium formulation. However, a harsh reality is plaguing global procurement managers: You may be paying liposome prices for "phospholipid mixtures."
What is Liposomal Technology?
Liposomes are an advanced microscopic delivery system. Composed of a phospholipid bilayer, their structure is highly similar to human cell membranes.
Four Core Advantages of Liposomal Technology
1. Targeted Brain Delivery
Liposomal 5-HTP mimics natural membranes, facilitating more effective transport across the blood-brain barrier for optimized neuro-uptake.
2. Reduced Side Effects
By encapsulating the extract, the direct interaction with gut serotonin receptors is minimized, significantly reducing nausea and GI distress.
3. Prevention of Decay
The lipid shell protects the volatile 5-HTP molecules from premature enzymatic breakdown in the peripheral circulatory system.
4. Improved Compliance
Enhanced bioavailability allows for lower clinical dosages to achieve superior mood and sleep results compared to bulk powder.
Specifications & Concentration

The percentage concentration (e.g., 25%, 50%, or 70%) designated for our Liposomal series represents the Active Ingredient Loading Capacity by weight relative to the total formulation. This metric defines the precise mass of the encapsulated bioactive compound within the lipid bilayer matrix.
A lower percentage typically signifies a higher ratio of phospholipids, which optimizes encapsulation efficiency and aqueous stability, whereas a higher percentage is engineered for maximum potency in space-constrained applications like solid dosage forms.
Certificate of Analysis
| Product Name | Griffonia Seed Extract | Part Used | Seed |
| Batch No. | CRSB20260224 | Package | 25kg/Drum |
| Manufacturing Date | 2026-02-24 | Quantity | 200 kg |
| Test Date | 2026-02-25 | Expiry Date | 2028-02-23 |
| Items | Standards | Method | Results |
| Physical Analysis | |||
| Appearance | White Powder | Visual | Complies |
| Assay 5-HTP | ≥98% | HPLC | 98.2% |
| Mesh | 100 % pass 80 mesh | 80 Mesh Screen | Complies |
| Loss on Drying | ≤5.0% | 5g/105℃/3h | 2.4% |
| Ash | ≤3.0% | 5g/700-800℃/5h | 1.9% |
| Sulfated ash | ≤1.5% | 5g/700-800℃/5h | 0.8% |
| PH | 5.0-7.0 | PH Paper | 5.8 |
| Alcohol residue | ≤0.5% | GC | Negative |
| Chemical | |||
| Lead (Pb) | ≤2ppm | ICP | Complies |
| Arsenic(As) | ≤0.5ppm | ICP | Complies |
| Mercury(Hg) | ≤0.3ppm | ICP | Complies |
| BHC | ≤10ppb | GC | Negative |
| DDT | ≤10ppb | GC | Negative |
| PCNB | ≤0.5ppm | GC | Negative |
| Microbiological Analysis | |||
| Total Plate Count | ≤ 1000cfu/g | CP2010 | 10 |
| Yeast & Mold | ≤ 100cfu/g | CP2010 | Complies |
| Colifoms | Negative | CP2010 | Complies |
| Salmonella | Negative | CP2010 | Negative |
| Shelf Life | 24 months under the conditions below, no antioxidant used | ||
| Package | 25 kg/carton outside and double food plastic bags inside. | ||
| Storage | Store in a cool, dry place away from Moisture, Light, Oxygen | ||







